Global Gadobutrol (CAS 138071-82-6) Sales Market Report 2021

Global Gadobutrol (CAS 138071-82-6) Sales Market Report 2021

Table of Contents
1 Gadobutrol (CAS 138071-82-6) Market Overview
1.1 Gadobutrol (CAS 138071-82-6) Product Scope
1.2 Gadobutrol (CAS 138071-82-6) Segment by Type
1.2.1 Global Gadobutrol (CAS 138071-82-6) Sales by Type (2016 & 2021 & 2027)
1.2.2 Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
1.2.3 Pharmacy Bulk Packages (30 mL and 65 mL)
1.3 Gadobutrol (CAS 138071-82-6) Segment by Application
1.3.1 Global Gadobutrol (CAS 138071-82-6) Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Adults
1.3.3 Children
1.4 Gadobutrol (CAS 138071-82-6) Market Estimates and Forecasts (2016-2027)
1.4.1 Global Gadobutrol (CAS 138071-82-6) Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Gadobutrol (CAS 138071-82-6) Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Gadobutrol (CAS 138071-82-6) Price Trends (2016-2027)
2 Gadobutrol (CAS 138071-82-6) Estimates and Forecasts by Region
2.1 Global Gadobutrol (CAS 138071-82-6) Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Gadobutrol (CAS 138071-82-6) Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Region (2016-2021)
2.2.2 Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Region (2016-2021)
2.3 Global Gadobutrol (CAS 138071-82-6) Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Gadobutrol (CAS 138071-82-6) Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Gadobutrol (CAS 138071-82-6) Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Gadobutrol (CAS 138071-82-6) Estimates and Projections (2016-2027)
2.4.2 Europe Gadobutrol (CAS 138071-82-6) Estimates and Projections (2016-2027)
2.4.3 China Gadobutrol (CAS 138071-82-6) Estimates and Projections (2016-2027)
2.4.4 Japan Gadobutrol (CAS 138071-82-6) Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Gadobutrol (CAS 138071-82-6) Estimates and Projections (2016-2027)
2.4.6 India Gadobutrol (CAS 138071-82-6) Estimates and Projections (2016-2027)
3 Global Gadobutrol (CAS 138071-82-6) Competition Landscape by Players
3.1 Global Top Gadobutrol (CAS 138071-82-6) Players by Sales (2016-2021)
3.2 Global Top Gadobutrol (CAS 138071-82-6) Players by Revenue (2016-2021)
3.3 Global Gadobutrol (CAS 138071-82-6) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gadobutrol (CAS 138071-82-6) as of 2020)
3.4 Global Gadobutrol (CAS 138071-82-6) Average Price by Company (2016-2021)
3.5 Manufacturers Gadobutrol (CAS 138071-82-6) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Gadobutrol (CAS 138071-82-6) Market Size by Type
4.1 Global Gadobutrol (CAS 138071-82-6) Historic Market Review by Type (2016-2021)
4.1.1 Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2016-2021)
4.1.2 Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Type (2016-2021)
4.1.3 Global Gadobutrol (CAS 138071-82-6) Price by Type (2016-2021)
4.2 Global Gadobutrol (CAS 138071-82-6) Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Gadobutrol (CAS 138071-82-6) Sales Forecast by Type (2022-2027)
4.2.2 Global Gadobutrol (CAS 138071-82-6) Revenue Forecast by Type (2022-2027)
4.2.3 Global Gadobutrol (CAS 138071-82-6) Price Forecast by Type (2022-2027)
5 Global Gadobutrol (CAS 138071-82-6) Market Size by Application
5.1 Global Gadobutrol (CAS 138071-82-6) Historic Market Review by Application (2016-2021)
5.1.1 Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2016-2021)
5.1.2 Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Application (2016-2021)
5.1.3 Global Gadobutrol (CAS 138071-82-6) Price by Application (2016-2021)
5.2 Global Gadobutrol (CAS 138071-82-6) Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Gadobutrol (CAS 138071-82-6) Sales Forecast by Application (2022-2027)
5.2.2 Global Gadobutrol (CAS 138071-82-6) Revenue Forecast by Application (2022-2027)
5.2.3 Global Gadobutrol (CAS 138071-82-6) Price Forecast by Application (2022-2027)
6 North America Gadobutrol (CAS 138071-82-6) Market Facts & Figures
6.1 North America Gadobutrol (CAS 138071-82-6) Sales by Company
6.1.1 North America Gadobutrol (CAS 138071-82-6) Sales by Company (2016-2021)
6.1.2 North America Gadobutrol (CAS 138071-82-6) Revenue by Company (2016-2021)
6.2 North America Gadobutrol (CAS 138071-82-6) Sales Breakdown by Type
6.2.1 North America Gadobutrol (CAS 138071-82-6) Sales Breakdown by Type (2016-2021)
6.2.2 North America Gadobutrol (CAS 138071-82-6) Sales Breakdown by Type (2022-2027)
6.3 North America Gadobutrol (CAS 138071-82-6) Sales Breakdown by Application
6.3.1 North America Gadobutrol (CAS 138071-82-6) Sales Breakdown by Application (2016-2021)
6.3.2 North America Gadobutrol (CAS 138071-82-6) Sales Breakdown by Application (2022-2027)
7 Europe Gadobutrol (CAS 138071-82-6) Market Facts & Figures
7.1 Europe Gadobutrol (CAS 138071-82-6) Sales by Company
7.1.1 Europe Gadobutrol (CAS 138071-82-6) Sales by Company (2016-2021)
7.1.2 Europe Gadobutrol (CAS 138071-82-6) Revenue by Company (2016-2021)
7.2 Europe Gadobutrol (CAS 138071-82-6) Sales Breakdown by Type
7.2.1 Europe Gadobutrol (CAS 138071-82-6) Sales Breakdown by Type (2016-2021)
7.2.2 Europe Gadobutrol (CAS 138071-82-6) Sales Breakdown by Type (2022-2027)
7.3 Europe Gadobutrol (CAS 138071-82-6) Sales Breakdown by Application
7.3.1 Europe 118 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 118 Sales Breakdown by Application (2022-2027)
8 China Gadobutrol (CAS 138071-82-6) Market Facts & Figures
8.1 China Gadobutrol (CAS 138071-82-6) Sales by Company
8.1.1 China Gadobutrol (CAS 138071-82-6) Sales by Company (2016-2021)
8.1.2 China Gadobutrol (CAS 138071-82-6) Revenue by Company (2016-2021)
8.2 China Gadobutrol (CAS 138071-82-6) Sales Breakdown by Type
8.2.1 China Gadobutrol (CAS 138071-82-6) Sales Breakdown by Type (2016-2021)
8.2.2 China Gadobutrol (CAS 138071-82-6) Sales Breakdown by Type (2022-2027)
8.3 China Gadobutrol (CAS 138071-82-6) Sales Breakdown by Application
8.3.1 China 144 Sales Breakdown by Application (2016-2021)
8.3.2 China 144 Sales Breakdown by Application (2022-2027)
9 Japan Gadobutrol (CAS 138071-82-6) Market Facts & Figures
9.1 Japan Gadobutrol (CAS 138071-82-6) Sales by Company
9.1.1 Japan Gadobutrol (CAS 138071-82-6) Sales by Company (2016-2021)
9.1.2 Japan Gadobutrol (CAS 138071-82-6) Revenue by Company (2016-2021)
9.2 Japan Gadobutrol (CAS 138071-82-6) Sales Breakdown by Type
9.2.1 Japan Gadobutrol (CAS 138071-82-6) Sales Breakdown by Type (2016-2021)
9.2.2 Japan Gadobutrol (CAS 138071-82-6) Sales Breakdown by Type (2022-2027)
9.3 Japan Gadobutrol (CAS 138071-82-6) Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Gadobutrol (CAS 138071-82-6) Market Facts & Figures
10.1 Southeast Asia Gadobutrol (CAS 138071-82-6) Sales by Company
10.1.1 Southeast Asia Gadobutrol (CAS 138071-82-6) Sales by Company (2016-2021)
10.1.2 Southeast Asia Gadobutrol (CAS 138071-82-6) Revenue by Company (2016-2021)
10.2 Southeast Asia Gadobutrol (CAS 138071-82-6) Sales Breakdown by Type
10.2.1 Southeast Asia Gadobutrol (CAS 138071-82-6) Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Gadobutrol (CAS 138071-82-6) Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Gadobutrol (CAS 138071-82-6) Sales Breakdown by Application
10.3.1 Southeast Asia M L Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M L Sales Breakdown by Application (2022-2027)
11 India Gadobutrol (CAS 138071-82-6) Market Facts & Figures
11.1 India Gadobutrol (CAS 138071-82-6) Sales by Company
11.1.1 India Gadobutrol (CAS 138071-82-6) Sales by Company (2016-2021)
11.1.2 India Gadobutrol (CAS 138071-82-6) Revenue by Company (2016-2021)
11.2 India Gadobutrol (CAS 138071-82-6) Sales Breakdown by Type
11.2.1 India Gadobutrol (CAS 138071-82-6) Sales Breakdown by Type (2016-2021)
11.2.2 India Gadobutrol (CAS 138071-82-6) Sales Breakdown by Type (2022-2027)
11.3 India Gadobutrol (CAS 138071-82-6) Sales Breakdown by Application
11.3.1 India Gadobutrol (CAS 138071-82-6) Sales Breakdown by Application (2016-2021)
11.3.2 India Gadobutrol (CAS 138071-82-6) Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Gadobutrol (CAS 138071-82-6) Business
12.1 Bayer HealthCare Pharmaceuticals
12.1.1 Bayer HealthCare Pharmaceuticals Corporation Information
12.1.2 Bayer HealthCare Pharmaceuticals Business Overview
12.1.3 Bayer HealthCare Pharmaceuticals Gadobutrol (CAS 138071-82-6) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bayer HealthCare Pharmaceuticals Gadobutrol (CAS 138071-82-6) Products Offered
12.1.5 Bayer HealthCare Pharmaceuticals Recent Development
12.2 SWAPNROOP DRUGS & PHARMACEUTICALS
12.2.1 SWAPNROOP DRUGS & PHARMACEUTICALS Corporation Information
12.2.2 SWAPNROOP DRUGS & PHARMACEUTICALS Business Overview
12.2.3 SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Products Offered
12.2.5 SWAPNROOP DRUGS & PHARMACEUTICALS Recent Development
12.3 Manus Aktteva Biopharma
12.3.1 Manus Aktteva Biopharma Corporation Information
12.3.2 Manus Aktteva Biopharma Business Overview
12.3.3 Manus Aktteva Biopharma Gadobutrol (CAS 138071-82-6) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Manus Aktteva Biopharma Gadobutrol (CAS 138071-82-6) Products Offered
12.3.5 Manus Aktteva Biopharma Recent Development
12.4 Jilin Tely Imp & Exp
12.4.1 Jilin Tely Imp & Exp Corporation Information
12.4.2 Jilin Tely Imp & Exp Business Overview
12.4.3 Jilin Tely Imp & Exp Gadobutrol (CAS 138071-82-6) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Jilin Tely Imp & Exp Gadobutrol (CAS 138071-82-6) Products Offered
12.4.5 Jilin Tely Imp & Exp Recent Development
12.5 JinYan Chemicals (ShangHai)
12.5.1 JinYan Chemicals (ShangHai) Corporation Information
12.5.2 JinYan Chemicals (ShangHai) Business Overview
12.5.3 JinYan Chemicals (ShangHai) Gadobutrol (CAS 138071-82-6) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 JinYan Chemicals (ShangHai) Gadobutrol (CAS 138071-82-6) Products Offered
12.5.5 JinYan Chemicals (ShangHai) Recent Development
12.6 BOC Sciences
12.6.1 BOC Sciences Corporation Information
12.6.2 BOC Sciences Business Overview
12.6.3 BOC Sciences Gadobutrol (CAS 138071-82-6) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 BOC Sciences Gadobutrol (CAS 138071-82-6) Products Offered
12.6.5 BOC Sciences Recent Development
12.7 LGM Pharma
12.7.1 LGM Pharma Corporation Information
12.7.2 LGM Pharma Business Overview
12.7.3 LGM Pharma Gadobutrol (CAS 138071-82-6) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 LGM Pharma Gadobutrol (CAS 138071-82-6) Products Offered
12.7.5 LGM Pharma Recent Development
12.8 Advanced Technology & Industrail
12.8.1 Advanced Technology & Industrail Corporation Information
12.8.2 Advanced Technology & Industrail Business Overview
12.8.3 Advanced Technology & Industrail Gadobutrol (CAS 138071-82-6) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Advanced Technology & Industrail Gadobutrol (CAS 138071-82-6) Products Offered
12.8.5 Advanced Technology & Industrail Recent Development
12.9 MedKoo Biosciences
12.9.1 MedKoo Biosciences Corporation Information
12.9.2 MedKoo Biosciences Business Overview
12.9.3 MedKoo Biosciences Gadobutrol (CAS 138071-82-6) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 MedKoo Biosciences Gadobutrol (CAS 138071-82-6) Products Offered
12.9.5 MedKoo Biosciences Recent Development
13 Gadobutrol (CAS 138071-82-6) Manufacturing Cost Analysis
13.1 Gadobutrol (CAS 138071-82-6) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Gadobutrol (CAS 138071-82-6)
13.4 Gadobutrol (CAS 138071-82-6) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Gadobutrol (CAS 138071-82-6) Distributors List
14.3 Gadobutrol (CAS 138071-82-6) Customers
15 Market Dynamics
15.1 Gadobutrol (CAS 138071-82-6) Market Trends
15.2 Gadobutrol (CAS 138071-82-6) Drivers
15.3 Gadobutrol (CAS 138071-82-6) Market Challenges
15.4 Gadobutrol (CAS 138071-82-6) Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Gadobutrol (CAS 138071-82-6) Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Gadobutrol (CAS 138071-82-6) Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Gadobutrol (CAS 138071-82-6) Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Gadobutrol (CAS 138071-82-6) Sales (M L) by Region (2016-2021)
Table 5. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Region (2016-2021)
Table 6. Global Gadobutrol (CAS 138071-82-6) Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Gadobutrol (CAS 138071-82-6) Revenue Share by Region (2016-2021)
Table 8. Global Gadobutrol (CAS 138071-82-6) Sales (M L) Forecast by Region (2022-2027)
Table 9. Global Gadobutrol (CAS 138071-82-6) Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Gadobutrol (CAS 138071-82-6) Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Gadobutrol (CAS 138071-82-6) Revenue Share Forecast by Region (2022-2027)
Table 12. Global Gadobutrol (CAS 138071-82-6) Sales (M L) of Key Companies (2016-2021)
Table 13. Global Gadobutrol (CAS 138071-82-6) Sales Share by Company (2016-2021)
Table 14. Global Gadobutrol (CAS 138071-82-6) Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Gadobutrol (CAS 138071-82-6) Revenue Share by Company (2016-2021)
Table 16. Global Gadobutrol (CAS 138071-82-6) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gadobutrol (CAS 138071-82-6) as of 2020)
Table 17. Global Gadobutrol (CAS 138071-82-6) Average Price (USD/L) of Key Company (2016-2021)
Table 18. Manufacturers Gadobutrol (CAS 138071-82-6) Manufacturing Sites and Area Served
Table 19. Manufacturers Gadobutrol (CAS 138071-82-6) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Gadobutrol (CAS 138071-82-6) Sales (M L) by Type (2016-2021)
Table 22. Global Gadobutrol (CAS 138071-82-6) Sales Share by Type (2016-2021)
Table 23. Global Gadobutrol (CAS 138071-82-6) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Gadobutrol (CAS 138071-82-6) Price (USD/L) by Type (2016-2021)
Table 25. Global Gadobutrol (CAS 138071-82-6) Sales Share by Type (2022-2027)
Table 26. Global Gadobutrol (CAS 138071-82-6) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Gadobutrol (CAS 138071-82-6) Revenue Share by Type (2022-2027)
Table 28. Global Gadobutrol (CAS 138071-82-6) Price (USD/L) by Type (2022-2027)
Table 29. Global Gadobutrol (CAS 138071-82-6) Sales (M L) by Application (2016-2021)
Table 30. Global Gadobutrol (CAS 138071-82-6) Sales Share by Application (2016-2021)
Table 31. Global Gadobutrol (CAS 138071-82-6) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Gadobutrol (CAS 138071-82-6) Price (USD/L) by Application (2016-2021)
Table 33. Global Gadobutrol (CAS 138071-82-6) Sales (M L) by Application (2022-2027)
Table 34. Global Gadobutrol (CAS 138071-82-6) Sales Share by Application (2022-2027)
Table 35. Global Gadobutrol (CAS 138071-82-6) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Gadobutrol (CAS 138071-82-6) Revenue Share by Application (2022-2027)
Table 37. Global Gadobutrol (CAS 138071-82-6) Price (USD/L) by Application (2022-2027)
Table 38. North America Gadobutrol (CAS 138071-82-6) Sales (M L) by Company (2016-2021)
Table 39. North America Gadobutrol (CAS 138071-82-6) Sales Market Share by Company (2016-2021)
Table 40. North America Gadobutrol (CAS 138071-82-6) Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Gadobutrol (CAS 138071-82-6) Revenue Market Share by Company (2016-2021)
Table 42. North America Gadobutrol (CAS 138071-82-6) Sales by Type (2016-2021) & (M L)
Table 43. North America Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2016-2021)
Table 44. North America Gadobutrol (CAS 138071-82-6) Sales by Type (2022-2027) & (M L)
Table 45. North America Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2022-2027)
Table 46. North America Gadobutrol (CAS 138071-82-6) Sales by Application (2016-2021) & (M L)
Table 47. North America Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2016-2021)
Table 48. North America Gadobutrol (CAS 138071-82-6) Sales by Application (2022-2027) & (M L)
Table 49. North America Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2022-2027)
Table 50. Europe Gadobutrol (CAS 138071-82-6) Sales (M L) by Company (2016-2021)
Table 51. Europe Gadobutrol (CAS 138071-82-6) Sales Market Share by Company (2016-2021)
Table 52. Europe Gadobutrol (CAS 138071-82-6) Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Gadobutrol (CAS 138071-82-6) Revenue Market Share by Company (2016-2021)
Table 54. Europe Gadobutrol (CAS 138071-82-6) Sales by Type (2016-2021) & (M L)
Table 55. Europe Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2016-2021)
Table 56. Europe Gadobutrol (CAS 138071-82-6) Sales by Type (2022-2027) & (M L)
Table 57. Europe Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2022-2027)
Table 58. Europe Gadobutrol (CAS 138071-82-6) Sales by Application (2016-2021) & (M L)
Table 59. Europe Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2016-2021)
Table 60. Europe Gadobutrol (CAS 138071-82-6) Sales by Application (2022-2027) & (M L)
Table 61. Europe Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2022-2027)
Table 62. China Gadobutrol (CAS 138071-82-6) Sales (M L) by Company (2016-2021)
Table 63. China Gadobutrol (CAS 138071-82-6) Sales Market Share by Company (2016-2021)
Table 64. China Gadobutrol (CAS 138071-82-6) Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Gadobutrol (CAS 138071-82-6) Revenue Market Share by Company (2016-2021)
Table 66. China Gadobutrol (CAS 138071-82-6) Sales by Type (2016-2021) & (M L)
Table 67. China Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2016-2021)
Table 68. China Gadobutrol (CAS 138071-82-6) Sales by Type (2022-2027) & (M L)
Table 69. China Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2022-2027)
Table 70. China Gadobutrol (CAS 138071-82-6) Sales by Application (2016-2021) & (M L)
Table 71. China Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2016-2021)
Table 72. China Gadobutrol (CAS 138071-82-6) Sales by Application (2022-2027) & (M L)
Table 73. China Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2022-2027)
Table 74. Japan Gadobutrol (CAS 138071-82-6) Sales (M L) by Company (2016-2021)
Table 75. Japan Gadobutrol (CAS 138071-82-6) Sales Market Share by Company (2016-2021)
Table 76. Japan Gadobutrol (CAS 138071-82-6) Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Gadobutrol (CAS 138071-82-6) Revenue Market Share by Company (2016-2021)
Table 78. Japan Gadobutrol (CAS 138071-82-6) Sales by Type (2016-2021) & (M L)
Table 79. Japan Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2016-2021)
Table 80. Japan Gadobutrol (CAS 138071-82-6) Sales by Type (2022-2027) & (M L)
Table 81. Japan Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2022-2027)
Table 82. Japan Gadobutrol (CAS 138071-82-6) Sales by Application (2016-2021) & (M L)
Table 83. Japan Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2016-2021)
Table 84. Japan Gadobutrol (CAS 138071-82-6) Sales by Application (2022-2027) & (M L)
Table 85. Japan Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Gadobutrol (CAS 138071-82-6) Sales (M L) by Company (2016-2021)
Table 87. Southeast Asia Gadobutrol (CAS 138071-82-6) Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Gadobutrol (CAS 138071-82-6) Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Gadobutrol (CAS 138071-82-6) Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Gadobutrol (CAS 138071-82-6) Sales by Type (2016-2021) & (M L)
Table 91. Southeast Asia Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Gadobutrol (CAS 138071-82-6) Sales by Type (2022-2027) & (M L)
Table 93. Southeast Asia Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Gadobutrol (CAS 138071-82-6) Sales by Application (2016-2021) & (M L)
Table 95. Southeast Asia Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Gadobutrol (CAS 138071-82-6) Sales by Application (2022-2027) & (M L)
Table 97. Southeast Asia Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2022-2027)
Table 98. India Gadobutrol (CAS 138071-82-6) Sales (M L) by Company (2016-2021)
Table 99. India Gadobutrol (CAS 138071-82-6) Sales Market Share by Company (2016-2021)
Table 100. India Gadobutrol (CAS 138071-82-6) Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Gadobutrol (CAS 138071-82-6) Revenue Market Share by Company (2016-2021)
Table 102. India Gadobutrol (CAS 138071-82-6) Sales by Type (2016-2021) & (M L)
Table 103. India Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2016-2021)
Table 104. India Gadobutrol (CAS 138071-82-6) Sales by Type (2022-2027) & (M L)
Table 105. India Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2022-2027)
Table 106. India Gadobutrol (CAS 138071-82-6) Sales by Application (2016-2021) & (M L)
Table 107. India Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2016-2021)
Table 108. India Gadobutrol (CAS 138071-82-6) Sales by Application (2022-2027) & (M L)
Table 109. India Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2022-2027)
Table 110. Bayer HealthCare Pharmaceuticals Corporation Information
Table 111. Bayer HealthCare Pharmaceuticals Description and Business Overview
Table 112. Bayer HealthCare Pharmaceuticals Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue (Million USD), Price (USD/L) and Gross Margin (2016-2021)
Table 113. Bayer HealthCare Pharmaceuticals Gadobutrol (CAS 138071-82-6) Product
Table 114. Bayer HealthCare Pharmaceuticals Recent Development
Table 115. SWAPNROOP DRUGS & PHARMACEUTICALS Corporation Information
Table 116. SWAPNROOP DRUGS & PHARMACEUTICALS Description and Business Overview
Table 117. SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue (Million USD), Price (USD/L) and Gross Margin (2016-2021)
Table 118. SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Product
Table 119. SWAPNROOP DRUGS & PHARMACEUTICALS Recent Development
Table 120. Manus Aktteva Biopharma Corporation Information
Table 121. Manus Aktteva Biopharma Description and Business Overview
Table 122. Manus Aktteva Biopharma Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue (Million USD), Price (USD/L) and Gross Margin (2016-2021)
Table 123. Manus Aktteva Biopharma Gadobutrol (CAS 138071-82-6) Product
Table 124. Manus Aktteva Biopharma Recent Development
Table 125. Jilin Tely Imp & Exp Corporation Information
Table 126. Jilin Tely Imp & Exp Description and Business Overview
Table 127. Jilin Tely Imp & Exp Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue (Million USD), Price (USD/L) and Gross Margin (2016-2021)
Table 128. Jilin Tely Imp & Exp Gadobutrol (CAS 138071-82-6) Product
Table 129. Jilin Tely Imp & Exp Recent Development
Table 130. JinYan Chemicals (ShangHai) Corporation Information
Table 131. JinYan Chemicals (ShangHai) Description and Business Overview
Table 132. JinYan Chemicals (ShangHai) Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue (Million USD), Price (USD/L) and Gross Margin (2016-2021)
Table 133. JinYan Chemicals (ShangHai) Gadobutrol (CAS 138071-82-6) Product
Table 134. JinYan Chemicals (ShangHai) Recent Development
Table 135. BOC Sciences Corporation Information
Table 136. BOC Sciences Description and Business Overview
Table 137. BOC Sciences Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue (Million USD), Price (USD/L) and Gross Margin (2016-2021)
Table 138. BOC Sciences Gadobutrol (CAS 138071-82-6) Product
Table 139. BOC Sciences Recent Development
Table 140. LGM Pharma Corporation Information
Table 141. LGM Pharma Description and Business Overview
Table 142. LGM Pharma Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue (Million USD), Price (USD/L) and Gross Margin (2016-2021)
Table 143. LGM Pharma Gadobutrol (CAS 138071-82-6) Product
Table 144. LGM Pharma Recent Development
Table 145. Advanced Technology & Industrail Corporation Information
Table 146. Advanced Technology & Industrail Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue (Million USD), Price (USD/L) and Gross Margin (2016-2021)
Table 147. Advanced Technology & Industrail Description and Business Overview
Table 148. Advanced Technology & Industrail Gadobutrol (CAS 138071-82-6) Product
Table 149. Advanced Technology & Industrail Recent Development
Table 150. MedKoo Biosciences Corporation Information
Table 151. MedKoo Biosciences Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue (Million USD), Price (USD/L) and Gross Margin (2016-2021)
Table 152. MedKoo Biosciences Description and Business Overview
Table 153. MedKoo Biosciences Gadobutrol (CAS 138071-82-6) Product
Table 154. MedKoo Biosciences Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Gadobutrol (CAS 138071-82-6) Distributors List
Table 158. Gadobutrol (CAS 138071-82-6) Customers List
Table 159. Gadobutrol (CAS 138071-82-6) Market Trends
Table 160. Gadobutrol (CAS 138071-82-6) Market Drivers
Table 161. Gadobutrol (CAS 138071-82-6) Market Challenges
Table 162. Gadobutrol (CAS 138071-82-6) Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Gadobutrol (CAS 138071-82-6) Product Picture
Figure 2. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Type in 2021 & 2027
Figure 3. Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL) Product Picture
Figure 4. Pharmacy Bulk Packages (30 mL and 65 mL) Product Picture
Figure 5. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Application in 2021 & 2027
Figure 6. Adults Examples
Figure 7. Children Examples
Figure 8. Global Gadobutrol (CAS 138071-82-6) Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Gadobutrol (CAS 138071-82-6) Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Gadobutrol (CAS 138071-82-6) Sales (M L) Growth Rate (2016-2027)
Figure 11. Global Gadobutrol (CAS 138071-82-6) Price Trends Growth Rate (2016-2027) (USD/L)
Figure 12. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Gadobutrol (CAS 138071-82-6) Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Gadobutrol (CAS 138071-82-6) Sales (M L) Growth Rate (2016-2027)
Figure 16. Europe Gadobutrol (CAS 138071-82-6) Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Gadobutrol (CAS 138071-82-6) Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Gadobutrol (CAS 138071-82-6) Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Gadobutrol (CAS 138071-82-6) Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Gadobutrol (CAS 138071-82-6) Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Gadobutrol (CAS 138071-82-6) Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Gadobutrol (CAS 138071-82-6) Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Gadobutrol (CAS 138071-82-6) Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Gadobutrol (CAS 138071-82-6) Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Gadobutrol (CAS 138071-82-6) Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Gadobutrol (CAS 138071-82-6) Players Market Share by Revenue in Gadobutrol (CAS 138071-82-6): 2016 & 2020
Figure 27. Gadobutrol (CAS 138071-82-6) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Gadobutrol (CAS 138071-82-6) Revenue Share by Type (2016-2021)
Figure 29. Global Gadobutrol (CAS 138071-82-6) Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Gadobutrol (CAS 138071-82-6) Revenue Share by Application (2016-2021)
Figure 31. Global Gadobutrol (CAS 138071-82-6) Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Gadobutrol (CAS 138071-82-6) Sales Market Share by Type in 2020
Figure 33. North America Gadobutrol (CAS 138071-82-6) Sales Market Share by Application in 2020
Figure 34. Europe Gadobutrol (CAS 138071-82-6) Sales Market Share by Type in 2020
Figure 35. Europe Gadobutrol (CAS 138071-82-6) Sales Market Share by Application in 2020
Figure 36. China Gadobutrol (CAS 138071-82-6) Sales Market Share by Type in 2020
Figure 37. China Gadobutrol (CAS 138071-82-6) Sales Market Share by Application in 2020
Figure 38. Japan Gadobutrol (CAS 138071-82-6) Sales Market Share by Type in 2020
Figure 39. Japan Gadobutrol (CAS 138071-82-6) Sales Market Share by Application in 2020
Figure 40. Southeast Asia Gadobutrol (CAS 138071-82-6) Sales Market Share by Type in 2020
Figure 41. Southeast Asia Gadobutrol (CAS 138071-82-6) Sales Market Share by Application in 2020
Figure 42. India Gadobutrol (CAS 138071-82-6) Sales Market Share by Type in 2020

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs